This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked RPS11 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RPS11 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~18.4 kDa | |
| Gel | 15% (standard starting point) | |
| Positive control | Small intestine (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A07622S11 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | lysates from HeLa and Jurkat cells, (catalog A07622S11) |
| Gel % | 15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.2 µm PVDF (standard starting point) |
| Blocking | the synthesized peptide (catalog A07622S11) |
| Primary antibody | A07622S11; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
RPS11 is predicted at 18.4 kDa; its annotated modifications could affect migration, but no empirical band or demonstrated shift is supplied.
| Single band near 18.4 kDa | Consistent with the predicted size of RPS11; confirm identity with antibody controls |
| Band in a cytoplasmic fraction | Consistent with the annotated cytoplasmic location |
| Band in a nuclear or nucleolar fraction | Consistent with the annotated nuclear and nucleolar location |
| Bands in both cytoplasmic and nuclear fractions | Consistent with the two annotated cellular locations |
| Predicted mass | Places the expected unmodified protein near 18.4 kDa |
| N-acetylalanine at residue 2 | Adds a small modification; a visible migration change is not established |
| N6-acetyllysine at residues 38, 45 and 58 | Adds modifications; their effect on apparent band size is not established |
| Phosphoserine at residues 67 and 110 | May affect migration if present, but no band shift is demonstrated |
| Citrulline at residue 22 and methylarginine at residue 69 | Mark modified residues without an established band-size effect |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Ribosome-associated or nucleolar RPS11 may be poorly recovered | Check extraction and loading, then compare cellular fractions |
| Band higher than expected | The listed modifications may affect migration, but no shift is established | Confirm identity with peptide competition or RPS11 depletion |
| Band lower than expected | No signal-peptide or propeptide cleavage is annotated | Confirm identity with RPS11 depletion and check sample integrity |
| Multiple bands | Modified RPS11 is annotated, but distinct migrating forms are unproven | Use peptide competition or RPS11 depletion to identify specific bands |
| Weak or no signal | Recovery of ribosome-associated RPS11 may be limited | Check loading, extraction and antibody performance |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Small intestine | glandular cells | High | Protein (IHC) | HPA → |
| Appendix | glandular cells | Medium | Protein (IHC) | HPA → |
| Cervix | squamous epithelial cells | Medium | Protein (IHC) | HPA → |
| Duodenum | glandular cells | Medium | Protein (IHC) | HPA → |
| Epididymis | glandular cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Not detected | Protein (IHC) | HPA → |
| Caudate | glial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for RPS11, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports A07622S11 for RPS11 Western blotting, with stated human, mouse, and rat reactivity. Its WB image shows HeLa and Jurkat lysates and a peptide-blocked lane; the supplied image does not show mouse or rat samples.
Which to pick: A07622S11 is the only listed option. It has a WB image using HeLa and Jurkat lysates. For mouse or rat samples, reactivity is listed, but no corresponding WB sample is shown.